Body Weight Monitoring
Objective: Track weight loss in transgenic mice receiving coenzyme Q10 and/or remacemide treatment to assess therapeutic effects on disease progression
Gather these items before starting the experiment. Check off items as you prepare.
Equipment1
Not specified • Not specified • Not specified • Not specified
As an Amazon Associate, we earn from qualifying purchases. Product links help support this free resource.
Protocol Steps
Baseline weight measurement
Measure initial body weight of transgenic mice prior to treatment initiation
Note: Baseline measurement needed to track weight loss progression
View evidence from paper
“weight loss in transgenic mice receiving treatment”
Administer oral treatment
Provide oral administration of coenzyme Q10 and/or remacemide to transgenic mice
Note: Combined treatment or single compound administration
View evidence from paper
“oral administration of either coenzyme Q 10 or remacemide significantly extended survival”
Monitor body weight
Regularly measure and record body weight of treated mice throughout the experimental period
Note: Weight loss is a key outcome measure for disease progression
View evidence from paper
“delayed the development of motor deficits, weight loss, cerebral atrophy, and neuronal intranuclear inclusions”